San Diego, California
Drop by our Booth #1141
Altasciences, a holding company, includes Algorithme Pharma, Algorithme Pharma USA and Vince & Associates Clinical Research, providing comprehensive early stage clinical drug development services in Phase I/ IIa, including the necessary support services in this critical stage of drug development. Our successful recruitment and retention of special populations in increasingly complex early development clinical trials allows us to best meet the changing needs of our industry.
an insightful presentation!
Exhibitor Hosted Session
Overcoming Challenges during Preclinical Sample Collection to Minimize the Impact on Toxicological Data
When conducting preclinical studies, maintaining sample integrity following collection is critical. Due to the complexity of pharmaceutical compounds, challenges that can impact data reliability may occur during and following sample collection. Potential issues include whole blood stability, anticoagulants, acid and preservatives, hemolyzed plasma and co-administered medications.
Spaces are limited!For more information
Let us know you
Jonathan R. St-Germain, PhD
Senior Scientist, Large Molecule Method Development, Algorithme Pharma
Jonathan St-Germain obtained his PhD in biochemistry from the University of Toronto (Toronto, Canada), before joining the Research and Development team at Algorithme Pharma (Laval, Canada) as Senior Scientist, LC-MS Large Molecule Quantification, within the Method Development group. Over the years, Jonathan has acquired extensive experience in the global and targeted quantification of proteins and their post-translational or chemical modifications using mass spectrometry and other biochemical tools. His work in this field has been published in various peer-reviewed journals, and presented at international events.